For patients with stage I-II malignant lymphoma with low-grade malignancy, five-year survival rates after radiation therapy are 75-100%. For patients with intermediate malignancy, five-year survival rates after radiation therapy alone are 70-100% for patients with pathological stage I-II and 45-75% for clinical stage I-II. Radiation dose to the tumor at least 40 Gy was required to produce consistent local control. Initial use of chemotherapy with radiation therapy is indicated to improve relapse-free survival rate for patients with clinical stage I-II, as well as pathological stage I-II.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
stage i-ii
20
radiation therapy
16
malignancy five-year
8
five-year survival
8
survival rates
8
rates radiation
8
pathological stage
8
clinical stage
8
radiation
5
stage
5
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!